Therefore, the observed combination of elevated ferritin and reduced serum iron levels in our MetS + and obesity groups is mainly driven by obesity-associated low-grade inflammation and the consequent activation of the IL-6–hepcidin axis, rather than by other inflammatory conditions. The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.